SCZ · Neurology · 5 drugs · 2 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Ulotaront | 4578 | TAAR1/5-HT1A Agonist | Small molecule | ORAL | PHASE3 |
| Vraylar | ABBV | D3/D2 partial agonist | Small molecule | PO | APPROVED |
| Rexulti | 4578 | Serotonin-Dopamine Activity Modulator (SDAM) | Small molecule | ORAL | APPROVED |
| Abilify Asimtufii | 4578 | Serotonin-Dopamine Activity Modulator (SDAM) | Small molecule | IM | APPROVED |
| Abilify Maintena | 4578 | Serotonin-Dopamine Activity Modulator (SDAM) | Small molecule | IM | APPROVED |